Avid Bioservices Inc (CDMO)

[nuke661]

Sunstar,

The way I read your post regarding the pancreatic trial you provided the link to was the trial was a combo therapy trial based on the statement in your post "(NP) + Gem, Phase 2 pancreatic trial, OS: 7.3 months".

When I read the link it appears to me that it was only a monotherapy trial that tested only nab-paclitaxel (NP) for patients who had progressed after being treated with gemcitabine (G).

From the abstract:

"This study was designed to determine the effectiveness of NP monotherapy in patients who progress on G-based therapy. "

Just trying to keep tht trial in proper perspective.